Oregon family’s life turned upside down after mom and son receive cancer diagnoses on the same day: ‘It was pretty surreal’ The family hopes the little boy will be home in time to celebrate Christmas The Independent UK · Nov 24, 2025
‘I’m most afraid of this’: Lawyer reveals the one common household product he refuses to touch, and it’s probably in your garage right now A scary household item warning We Got This Covered · Nov 24, 2025
Cancer Detectives: Finding the Cures review – this vaccine documentary is so inspirational it’ll make you weep The tale of Prof Sarah Blagden’s attempt to find a treatment that stops the disease is the rarest of things – TV that makes you dare to hope The Guardian - UK · Nov 20, 2025
Nuvalent Reports 31% Response Rate In Patients With Advanced Form Of Lung Cancer Nuvalent, Inc. (NASDAQ:NUVL) on Monday reported topline results from its ALKOVE-1 Phase 1/2 trial. Benzinga · Nov 17, 2025
Zymeworks, Jazz Pharmaceuticals Stocks Climb On Robust Gastroesophageal Trial Outcomes And Upcoming Regulatory Plans Zymeworks Inc. (NASDAQ:ZYME) stock is surging on Monday, with a session volume of 2.17 million, compared to an average volume of 728.75K, according to Benzinga Pro. Benzinga · Nov 17, 2025
NHS hospital performance in England: Latest numbers and trends Some 180,329 people had been waiting more than a year to start routine hospital treatment at the end of September. Evening Standard · Nov 13, 2025
EnGene Encouraged By Promising Response Rates In Bladder Cancer Trial enGene Holdings Inc. (NASDAQ:ENGN) stock is edging higher on Tuesday, with a session volume of 18.62 million compared to an average volume of 266.85 thousand, as per data from Benzinga Pro. Benzinga · Nov 11, 2025
South Carolina pays estate of patient who died following days in agony after surgeons left a blade inside him Jeffrey Alan Fulcher, a 58-year-old husband and father of three, died after a minimally invasive surgery The Independent UK · Nov 8, 2025
FDA Clears Johnson & Johnson's Darzalex Faspro, Enabling Early Intervention In Myeloma Progression The U.S. Food and Drug Administration (FDA) approved on Thursday Johnson Johnson’s (NYSE:JNJ) Darzalex Faspro (daratumumab and hyaluronidase-fihj) for a type of blood cancer. Benzinga · Nov 7, 2025
Blood Pressure Medication Recalled Because Of Cancer Risk: What Is Prazosin Hydrochloride Teva Pharmaceuticals orders a nationwide recall of their Prazosin Hydrochloride capsules. International Business Times UK · Oct 31, 2025
Tango Therapeutics Touts Encouraging Data From Early-Stage Cancer Trial, Raises Capital To Fund Advancement Tango Therapeutics Inc. (NASDAQ:TNGX) revealed data from its ongoing Phase 1/2 study of vopimetostat (TNG462) in patients with MTAP-deleted cancers. Benzinga · Oct 23, 2025
‘Tongue cancer made it hard to speak and eat - but new smart jab treatment changed my life’ Head and neck cancer is the sixth most common cancer worldwide, with around 12,800 new cases each year in the UK alone The Independent UK · Oct 20, 2025
AstraZeneca/Daiichi Sankyo Partnered Breast Cancer Drug Shows Survival Benefit Over Chemotherapy AstraZeneca Plc (NASDAQ:AZN) and Daiichi Sankyo on Monday released high-level results from the TROPION-Breast02 Phase 3 trial. Benzinga · Oct 6, 2025
Teddi Mellencamp's stage 4 cancer is 'gone' Teddi Mellencamp has been left in "shock" after being told that her stage 4 melanoma is "gone". BANG Premier · Oct 4, 2025
The Independent UK · Oct 1, 2025 Sunbeds should be banned in the UK to cut skin cancer rates, experts say Exposure to ultraviolet radiation from sunbeds was confirmed to be carcinogenic to humans in 2009 by the International Agency for Research on Cancer.
Metal Hammer · Sep 30, 2025 Sick Of It All singer Lou Koller says his oesophageal cancer has returned The hardcore vocalist was first diagnosed with the disease in summer 2024 and said he was cancer-free in May
Benzinga · Sep 26, 2025 Sanofi Expands Insulin Savings Program To Cover All US Patients The U.S. Food and Drug Administration removed the Risk Evaluation and Mitigation Strategies (REMS) program for Caprelsa (vandetanib), a thyroid cancer medication manufactured by Sanofi SA’s (NASDAQ: SNY) Genzyme Corporation.
The Guardian - UK · Sep 14, 2025 Three in four English hospitals failing to hit two cancer targets in league tables Exclusive: Cancer experts declare ‘national emergency’ as hospitals miss targets on diagnosis and starting treatment
The Independent UK · Sep 12, 2025 Warning after cancer patients died following delays in getting life-saving emergency drugs More than a dozen cancer patients have either died or become seriously ill after not getting rasburicase
BANG Premier · Sep 9, 2025 Bruce Dickinson: 'I sounded like a wounded buffalo after cancer treatment' Bruce Dickinson has opened up about his recovery from throat cancer treatment and how it impacted his voice.
Benzinga · Sep 2, 2025 EXCLUSIVE: Hoth Therapeutics' Antisense Therapy Demonstrates Efficacy Against KIT-Driven Cancers Hoth Therapeutics Inc. (NASDAQ:HOTH) on Tuesday announced combined findings from multiple preclinical programs evaluating its precision antisense candidate HT-KIT.
Benzinga · Aug 25, 2025 HCW Biologics' Shares Surge After Unveiling Next-Gen Cancer Immunotherapy Platform HCW Biologics Inc. (NASDAQ:HCWB) stock is trading higher on Monday, with a session volume of 10.85 million compared to the average volume of 132.51K as per data from Benzinga Pro.
The Independent UK · Aug 24, 2025 Thousands referred for liver cancer checks after on-the-spot scan Some 112,831 people have had a mobile scan of their liver under the NHS scheme
The Guardian - UK · Aug 20, 2025 Treatment that can double bladder cancer survival rates available to 1,000 patients in England People with disease that has spread have been found to live twice as long when given treatment hailed as ‘hopeful’
The Guardian - UK · Aug 14, 2025 Abortion drug could help reduce risk of breast cancer, group of medics says Stigma around mifepristone is stopping studies, experts in reproductive health claim in Lancet opinion piece